Clincosm LogoSign in Get a demo

Recurrent Melanoma

Showing 26 - 50 of 92
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Melanoma, Stage IV Melanoma, Tumors Metastatic to Brain Trial in Columbus, Philadelphia (Ipilimumab, Whole-Brain

Completed
Has Results
  • Recurrent Melanoma
  • +2 more
  • Columbus, Ohio
  • +1 more
Jul 12, 2019

Metastatic Melanoma, Recurrent Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in United States (Aldesleukin, Laboratory

Completed
Has Results
  • Metastatic Melanoma
  • +6 more
  • Aldesleukin
  • +2 more
  • Duarte, California
  • +20 more
May 9, 2019

Liver Metastases, Lung Metastases, Recurrent Melanoma Trial in Columbus (biological, radiation, other)

Unknown status
  • Liver Metastases
  • +4 more
  • ipilimumab
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 19, 2018

Recurrent Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in United States (Laboratory Biomarker Analysis, Pazopanib

Completed
Has Results
  • Recurrent Melanoma
  • Stage IV Cutaneous Melanoma AJCC v6 and v7
  • Laboratory Biomarker Analysis
  • +2 more
  • Jacksonville, Florida
  • +3 more
Sep 21, 2018

Recurrent Melanoma, Stage IIA Melanoma, Stage IIB Melanoma Trial in Rochester (drug, biological, other)

Completed
  • Recurrent Melanoma
  • +7 more
  • Montanide ISA 51 VG
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Oct 4, 2018

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute

Terminated
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +13 more
  • ipilimumab
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Sep 4, 2018

Acral Lentiginous Malignant Melanoma, Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma,

Completed
Has Results
  • Acral Lentiginous Malignant Melanoma
  • +10 more
  • cediranib maleate
  • Toronto, Ontario, Canada
    Princess Margaret Hospital Phase 2 Consortium
Jul 27, 2018

Recurrent Melanoma, Recurrent Pancreatic Cancer, Recurrent Renal Cell Cancer Trial in Winston-Salem (siRNA-transfected

Completed
  • Recurrent Melanoma
  • +11 more
  • siRNA-transfected peripheral blood mononuclear cells APN401
  • laboratory biomarker analysis
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jul 2, 2018

Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma Trial in Philadelphia (drug, biological, other)

Completed
Has Results
  • Recurrent Melanoma
  • +3 more
  • imatinib mesylate
  • +3 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
May 23, 2018

Extraocular Extension Melanoma, Metastatic Intraocular Melanoma, Recurrent Intraocular Melanoma Trial in Buffalo (axitinib,

Terminated
Has Results
  • Extraocular Extension Melanoma
  • +11 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 8, 2018

Recurrent Melanoma, Stage III Skin Melanoma, Stage IV Skin Melanoma Trial in San Antonio (biological, other, drug)

Completed
Has Results
  • Recurrent Melanoma
  • +2 more
  • Bevacizumab
  • +3 more
  • San Antonio, Texas
    Cancer Therapy and Research Center at The UT Health Science Cent
Oct 19, 2017

Recurrent Melanoma, Stage IIIA Skin Melanoma, Stage IIIB Skin Melanoma Trial in United States (biological, drug, other)

Completed
Has Results
  • Recurrent Melanoma
  • +4 more
  • Aldesleukin
  • +5 more
  • Birmingham, Alabama
  • +18 more
Nov 16, 2017

Recurrent Melanoma, Stage IIB Melanoma (Locally Advanced), Stage IIC Melanoma (Locally Advanced) Trial in Nashville (dabrafenib,

Terminated
Has Results
  • Recurrent Melanoma
  • +6 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Jun 20, 2017

Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial in Philadelphia, Charlottesville (biological,

Completed
Has Results
  • Recurrent Melanoma
  • +3 more
  • Bevacizumab
  • +3 more
  • Philadelphia, Pennsylvania
  • +1 more
May 5, 2017

Recurrent Melanoma Trial in Stanford (Indocyanine green solution, Isosulfan blue (ISB), Lymphoscintigraphy with 99-technetium

Completed
Has Results
  • Recurrent Melanoma
  • Indocyanine green solution
  • +2 more
  • Stanford, California
    Stanford University Hospitals and Clinics
Apr 19, 2017

Recurrent Melanoma, Stage IV Melanoma Trial in Seattle (biological, drug, procedure, other, genetic)

Completed
  • Recurrent Melanoma
  • Stage IV Melanoma
  • ipilimumab
  • +7 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Apr 17, 2017

Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in Nashville (diagnostic test, other, device)

Terminated
Has Results
  • Recurrent Melanoma
  • +4 more
  • [18F]fluorodeoxyglucose
  • +3 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Apr 12, 2017

Recurrent Melanoma Trial in United States (radiation therapy)

Completed
Has Results
  • Recurrent Melanoma
  • radiation therapy
  • Scottsdale, Arizona
  • +38 more
Jan 30, 2017

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Terminated
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +33 more
  • Ipilimumab
  • Radiation therapy
  • Stanford, California
    Stanford University
Jan 12, 2017

Recurrent Melanoma, Stage IA Melanoma, Stage IB Melanoma Trial in Portland (HPV 16 E7:12-20, gp100:209-217(210M), laboratory

Completed
Has Results
  • Recurrent Melanoma
  • +8 more
  • HPV 16 E7:12-20
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Dec 28, 2016

Recurrent Melanoma, Stage IV Melanoma Trial in Seattle (biological, drug, procedure, other, genetic)

Completed
  • Recurrent Melanoma
  • Stage IV Melanoma
  • therapeutic autologous lymphocytes
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 13, 2017

Recurrent Melanoma, Stage IV Skin Melanoma Trial in Chicago (NA17.A2 Peptide Vaccine, Recombinant MAGE-3.1 Antigen, Recombinant

Terminated
Has Results
  • Recurrent Melanoma
  • Stage IV Skin Melanoma
  • NA17.A2 Peptide Vaccine
  • +4 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Aug 31, 2016

Recurrent Melanoma, Stage IV Melanoma, Tumors Metastatic to Brain Trial (Vemurafenib, Whole-brain radiation therapy (WBRT),

Withdrawn
  • Recurrent Melanoma
  • +2 more
  • (no location specified)
Oct 19, 2016

Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Buffalo (biological, other, drug)

Completed
  • Anaplastic Astrocytoma
  • +64 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2016

Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Nodular Malignant Melanoma Trial in United States

Terminated
Has Results
  • Acral Lentiginous Malignant Melanoma
  • +6 more
  • gamma-secretase/Notch signalling pathway inhibitor RO4929097
  • laboratory biomarker analysis
  • Mobile, Alabama
  • +177 more
May 6, 2016